Ключевые слова:
ischemic heart disease, gastroesophageal reflux disease, NERD, chest pain, omeprazole test, GERD-Q.Библиографические ссылки
1. De Giorgi F., Palmiero M., Esposito I., Mosca F., Cuomo R. Pathophysiology of gastroesophageal reflux disease. Acta Otorhinolaryngol Ital. 2006;26(5):241–246.
2. Dent J., El-Serag H.B., Wallander M.A., Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–717.
3. Fass R. Empirical proton pump inhibitor therapy in patients with noncardiac chest pain. Am J Gastroenterol. 2002;97(3):542–548.
4. Fass R., Achem S.R. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil. 2011;17(2):110–123.
5. Fass R., Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil. 2006;18(6):408–417.
6. Flook N., Jones R. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Can J Gastroenterol. 2008;22(1):1–24.
7. Gerson L.B., Fass R. A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(4):372–378.
8. Gyawali C.P., Fass R. Management of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):302–318.
9. Kahrilas P.J., Shaheen N.J., Vaezi M.F. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135(4):1383–1391.
10. Katz P.O., Gerson L.B., Vela M.F. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–328.
11. Kusano M., Shimoyama Y., Sugimoto S. Development of GERD symptoms in patients with ischemic heart disease. J Gastroenterol. 2012;47(6):593–600.
12. Liu Y., Sun X., Li Y. Association between gastroesophageal reflux disease and ischemic heart disease: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(24):e15845.
13. Pandak W.M., Arezo S., Everett S. Gastroesophageal reflux disease and coronary artery disease: clinical implications. Am J Med. 2002;112(4):292–298.
14. Richter J.E. Chest pain and gastroesophageal reflux disease. J Clin Gastroenterol. 2000;30(3 Suppl):S39–S41.
15. Shaker R., Castell D.O., Schoenfeld P.S., Spechler S.J. Nighttime gastroesophageal reflux disease. Gastroenterology. 2003;124(4):1088–1092.
16. Sifrim D., Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012;61(9):1340–1354.
17. Vaezi M.F., Schroeder P.L., Richter J.E. Reproducibility of proximal pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92(5):825–829.
18. Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R. The GERD questionnaire (GERDQ): a tool for the diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2010;8(8):722–727.
19. Vakil R., van Zanten S.V., Kahrilas P. The Montreal definition and classification of gastroesophageal reflux disease. Am J Gastroenterol. 2006;101(8):1900–1920.
20. Wang W.H., Huang J.Q., Zheng G.F., Xia H.H., Wong W.M., Lam S.K. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis. Am J Gastroenterol. 2005;100(10):2190–2197.
